A new trading day began on Monday, with Moleculin Biotech Inc (NASDAQ: MBRX) stock price up 14.35% from the previous day of trading, before settling in for the closing price of $0.34. MBRX’s price has ranged from $0.25 to $4.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 26.36% over the last five years. Meanwhile, its annual earnings per share averaged 75.21%. With a float of $21.99 million, this company’s outstanding shares have now reached $24.10 million.
The firm has a total of 17 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Moleculin Biotech Inc (MBRX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Moleculin Biotech Inc is 8.74%, while institutional ownership is 6.13%. The most recent insider transaction that took place on Jun 23 ’25, was worth 100,000. In this transaction Chief Financial Officer of this company bought 270,270 shares at a rate of $0.37, taking the stock ownership to the 287,587 shares. Before that another transaction happened on Jun 23 ’25, when Company’s CEO and President bought 675,675 for $0.37, making the entire transaction worth $250,000. This insider now owns 743,607 shares in total.
Moleculin Biotech Inc (MBRX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 75.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.60% during the next five years compared to 26.36% growth over the previous five years of trading.
Moleculin Biotech Inc (NASDAQ: MBRX) Trading Performance Indicators
Here are Moleculin Biotech Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.80, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.36 in one year’s time.
Technical Analysis of Moleculin Biotech Inc (MBRX)
Analysing the last 5-days average volume posted by the [Moleculin Biotech Inc, MBRX], we can find that recorded value of 2.72 million was lower than the volume posted last year of 3.81 million. As of the previous 9 days, the stock’s Stochastic %D was 59.97%.
During the past 100 days, Moleculin Biotech Inc’s (MBRX) raw stochastic average was set at 4.08%, which indicates a significant decrease from 29.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 345.62% in the past 14 days, which was higher than the 261.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7663, while its 200-day Moving Average is $1.5672. Now, the first resistance to watch is $0.4149. This is followed by the second major resistance level at $0.4409. The third major resistance level sits at $0.4819. If the price goes on to break the first support level at $0.3479, it is likely to go to the next support level at $0.3069. Should the price break the second support level, the third support level stands at $0.2809.
Moleculin Biotech Inc (NASDAQ: MBRX) Key Stats
With a market capitalization of 9.37 million, the company has a total of 14,127K Shares Outstanding. Currently, annual sales are 0 K while annual income is -21,760 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,440 K.
